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Objectives: We have previously shown that the angio-
tensin converting enzyme inhibitor, ramipril, improved
walking distance and reduced arterial stiffness in patients
with intermittent claudication. In this analysis on the
same cohort of patients, we investigated whether ramipril’s
ability to improve walking distance is dependent on its
ability to reduce arterial stiffness.
Methods: 33 patients (25 males; mean age, 65 6 7.8)
with intermittent claudication were randomised to receive
ramipril (n ¼ 14) or placebo (n ¼ 19) for 24 weeks in
a double-blind fashion. Walking distance was assessed using
a standard treadmill test (1.6 mph at 10% incline) and arte-
rial stiffness indices were assessed using the SphygmoCor
device.
Results: After 24 weeks, ramipril improved maximum
treadmill walking distance; adjusted mean change differ-
ence (95% conﬁdence interval); by 130.5 metres (61.8
metres to 199.2 metres) longer than placebo (P ¼ .001)
and improved treadmill intermittent claudication distance
by 121.9 metres (55.9 metres to 187.8 metres) longer
than placebo (P ¼ .001). Ramipril reduced carotid femoral
pulse wave velocity (PWVcf) by 1.47 m/s (2.4 m/s to
0.57 m/s) compared to placebo (P ¼ .002) and reduced
augmentation index (AIx) by 10.8% (14.1% to 7.5%)
compared to placebo (P < .001). Changes in walking
distance from baseline showed signiﬁcant inverse correla-
tions with changes in indices of arterial stiffness (PWVcf,
r ¼ .43, P ¼ .021; AIx, r ¼ .50, P ¼ .006; AIx adjusted
to 75 beats/minute, r ¼.50, P¼ .006; central pulse pres-
sure, r ¼ .45, P ¼ .039). Correlations remained signiﬁ-
cant after adjusting for heart rate and mean arterial pressure.
Conclusions: Ramipril improves walking distance in
patients with intermittent claudication. This improvement
is partly due to ramipril’s ability to reduce arterial stiffness.
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Objectives: To compare the incidence of deep groin
wound infections between patients having peripheral arte-
rial disease (PAD)-related operations with standard groin
incision (SGI) vs those having exposure of the femoral
vessels via an approach lateral to sartorius muscle (LSM).
Methods: Consecutive patients (n ¼ 604) who under-
went PAD-related operations were matched on propensity
score (PS) calculated as their probability to have either the
SGI or the LSM approach on the basis of operative charac-
teristics, demographics and comorbidities. Primary end-
point was the incidence of deep groin wound infections.
Single level random effects logistic and Poisson regressions
were performed to analyze outcomes.
Results: After PS matching the groups were well-
balanced on all major covariates except for that of groin
reoperation; therefore, the ﬁnal regression models were
all adjusted for this predictor. The incidence of deep groin
wound infection was lower in the LSM group (2 vs 6.3%;
OR, 0.1; P ¼ .016). An interaction term between LSM
approach and reoperation approached statistical signiﬁ-
cance (P ¼ .07) and individual interaction component anal-
ysis indicated that the beneﬁcial effect of the LSM approach
was mainly in the patients undergoing groin reoperations.
Superﬁcial infections (OR, 0.83; P ¼ .88), intra-operative
blood loss (median, 275 vs 350 cc; IRR, 1.04; P ¼ .75),
operative time (median, 4.6 vs 4.9 hours; IRR, 1.01; P ¼
.875), and incidence of perioperative death and MI (OR,
1; P ¼ .99) were similar between the SGI and LSM groups
respectively. Postoperative length of stay (median, 6 vs 8
days; IRR, 1.3; P ¼ .052) was slightly higher in the LSM
group.
Conclusions: Patients having femoral vessel exposure
via a lateral to sartorius muscle approach have a substantially
lower risk of deep groin infections, particularly if under-
going reoperation.
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Objectives: Major Lower Extremity (MLE) amputa-
tion is a profound change in a patient’s life. We seek to
determine the role of social integration in outcomes after
